Target Name: ITIH5
NCBI ID: G80760
Review Report on ITIH5 Target / Biomarker Content of Review Report on ITIH5 Target / Biomarker
ITIH5
Other Name(s): ITIH5 variant 1 | Inter-alpha-trypsin inhibitor heavy chain H5 (isoform 1) | ITIH5_HUMAN | Inter-alpha-trypsin inhibitor heavy chain H5 | inter-alpha-trypsin inhibitor heavy chain 5 | PP14776 | ITI heavy chain H5 | Inter-alpha-inhibitor heavy chain 5 | inter-alpha (globulin) inhibitor H5 | ITI-HC5 | inter-alpha-trypsin inhibitor heavy chain family member 5 | Inter-alpha-trypsin inhibitor heavy chain 5, transcript variant 1 | pp14776

ITIH5: A Protein Involved in Cell Signaling and Immune Responses

ITIH5, or ITIH5 variant 1, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of inflammation and immune responses.

Recent studies have suggested that ITIH5 may be a drug target or biomarker for various diseases, including autoimmune disorders, neurodegenerative diseases, and cancer. This has led to increased interest in ITIH5 as a potential therapeutic approach.

One of the key features of ITIH5 is its ability to interact with various signaling pathways, including TGF-β and NF-kappa-B. These signaling pathways are involved in the regulation of cell growth, differentiation, and inflammation. ITIH5 has been shown to regulate the activity of these pathways, which suggests that it may play a role in the regulation of various cellular processes in the body.

In addition to its role in signaling pathways, ITIH5 has also been shown to have direct effects on various cellular processes. For example, studies have shown that ITIH5 can modulate the activity of immune cells, including natural killer cells and T cells. This suggests that ITIH5 may play a role in the regulation of immune responses.

The potential therapeutic benefits of ITIH5 are vast, as it has been shown to be involved in the regulation of various cellular processes that are involved in the development and progression of many diseases. As such, ITIH5 has been identified as a potential drug target or biomarker for a wide range of diseases, including autoimmune disorders, neurodegenerative diseases, and cancer.

In conclusion, ITIH5 is a protein that has been shown to play a role in the regulation of various cellular processes in the body. Its potential therapeutic benefits are vast, as it has been identified as a potential drug target or biomarker for a wide range of diseases. Further research is needed to fully understand the role of ITIH5 in the regulation of cellular processes and its potential as a therapeutic approach.

Protein Name: Inter-alpha-trypsin Inhibitor Heavy Chain 5

Functions: May act as a tumor suppressor

The "ITIH5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ITIH5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ITIH6 | ITK | ITLN1 | ITLN2 | ITM2A | ITM2B | ITM2C | ITPA | ITPK1 | ITPK1-AS1 | ITPKA | ITPKB | ITPKB-IT1 | ITPKC | ITPR1 | ITPR1-DT | ITPR2 | ITPR3 | ITPRID1 | ITPRID2 | ITPRIP | ITPRIPL1 | ITPRIPL2 | ITSN1 | ITSN2 | IVD | IVL | IVNS1ABP | IWS1 | IYD | IZUMO1 | IZUMO1R | IZUMO2 | IZUMO4 | JADE1 | JADE2 | JADE3 | JAG1 | JAG2 | JAGN1 | JAK1 | JAK2 | JAK3 | JAKMIP1 | JAKMIP1-DT | JAKMIP2 | JAKMIP2-AS1 | JAKMIP3 | JAM2 | JAM3 | JAML | Janus Kinase | JARID2 | JAZF1 | JAZF1-AS1 | JCAD | JDP2 | JHY | JKAMP | JMJD1C | JMJD1C-AS1 | JMJD4 | JMJD6 | JMJD7 | JMJD7-PLA2G4B | JMJD8 | JMY | JOSD1 | JOSD2 | JPH1 | JPH2 | JPH3 | JPH4 | JPT1 | JPT2 | JPX | JRK | JRKL | JSRP1 | JTB | JUN | JUNB | JUND | JUP | K(ATP) Channel | KAAG1 | Kainate Receptor (GluR) | Kallikrein | KALRN | KANK1 | KANK2 | KANK3 | KANK4 | KANSL1 | KANSL1-AS1 | KANSL1L | KANSL2 | KANSL3 | KANTR | KARS1